Cite

    K Lauper et al.. “SAT0206 Retention of tocilizumab as monotherapy versus tnf inhibitors with conventional synthetic dmards in rheumatoid arthritis patients with inadequate response to tnf inhibitors: a study from the tocerra collaboration.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 850–851. http://access.bl.uk/ark:/81055/vdc_100134878277.0x000063